Avelox is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is Moxifloxacin Hydrochloride.
Product ID | 50419-537_308257f1-8828-4071-b009-402d9092bd2d |
NDC | 50419-537 |
Product Type | Human Prescription Drug |
Proprietary Name | Avelox |
Generic Name | Moxifloxacin Hydrochloride |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2001-11-30 |
Marketing End Date | 2020-06-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021277 |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | MOXIFLOXACIN HYDROCHLORIDE |
Active Ingredient Strength | 400 mg/250mL |
Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS] |
NDC Exclude Flag | N |
Marketing Start Date | 2001-11-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021277 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2001-11-30 |
Marketing End Date | 2020-06-01 |
Ingredient | Strength |
---|---|
MOXIFLOXACIN HYDROCHLORIDE | 400 mg/250mL |
SPL SET ID: | 64b6763e-e6c6-4d7d-a0eb-e4bd6a5eed3a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0085-1733 | Avelox | moxifloxacin hydrochloride |
0085-1737 | Avelox | moxifloxacin hydrochloride |
50419-530 | Avelox | Avelox |
50419-537 | Avelox | Avelox |
67296-0154 | Avelox | Avelox |
0065-0006 | MOXEZA | moxifloxacin hydrochloride |
48792-7823 | Moxifloxacin | moxifloxacin hydrochloride |
0093-7387 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
0832-1410 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
13668-201 | moxifloxacin hydrochloride | moxifloxacin hydrochloride |
40032-034 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
43063-580 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
43063-585 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
47781-268 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
50090-4058 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
50090-4100 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
0781-7135 | Moxifloxacin Ophthalmic Solution | moxifloxacin hydrochloride |
0065-4013 | VIGAMOX | moxifloxacin hydrochloride |
0078-0939 | VIGAMOX | moxifloxacin hydrochloride |
21695-968 | VIGAMOX | moxifloxacin hydrochloride |
50090-0859 | VIGAMOX | moxifloxacin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AVELOX 78092603 2780658 Live/Registered |
Bayer Aktiengesellschaft 2001-11-09 |
AVELOX 75400008 2373382 Live/Registered |
Bayer Aktiengesellschaft 1997-12-04 |